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Epidemiological and biological studies indicate that solar UVB radiation is involved in cutaneous malignant
melanoma etiology. Indeed, melanocytes are very frequently exposed to solar UV radiation, which induces cell
damage and may promote cell transformation. We previously showed that melanocytes and melanoma cells
exposed to UVB radiation activates a p53-independent pathway involving Gadd45a and, more recently, that
Gadd45a plays a critical role in UVB-induced G2 cell cycle arrest of melanoma cells. In this study, we
demonstrate that the inhibition of UV-induced Gadd45a overexpression by RNA interference results in a
dramatic increase of cell death. We identify this cell death as apoptosis, with activation of Caspase-3 and a
decrease in Bcl-xL expression. Furthermore, we show that inhibition of UV-induced Gadd45a overexpression also
leads to increased sensitivity of melanoma cells to therapeutic agents such as DTIC and Cisplatin. We conclude
that UVB-induced Gadd45a overexpression protects melanoma cells from apoptosis, both by causing a G2 cell
cycle arrest and by inhibiting the mitochondrial apoptotic pathway. These observations suggest that Gadd45a
inactivation could be a useful way to sensitize melanoma cells to chemotherapy. JID JOURNAL CLUB ARTICLE: For
questions, answers, and open discussion about this article please go to http://network.nature.com/group/jidclub
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INTRODUCTION
Cutaneous malignant melanoma is the cancer with the most
rapidly increasing incidence in Europe (4–7% a year) (Boniol
et al., 2007). Advanced melanomas are associated with poor
prognosis, as, following removal of primary tumor and
sentinel lymph node, no adjuvant therapy has proven
effective to prevent metastasis development (Soengas and
Lowe, 2003).
The insensitivity of melanoma cells to radio- and
chemotherapy can, at least in part, be explained by the high
resistance of melanocytes to apoptosis as compared with
other cells. Melanocytes, which produce melanin in response
to solar UV radiation, are able to tolerate UV doses inducing
apoptosis in neighboring cells. Nevertheless, UV irradiation
induces damage in melanocytes and is considered the
predominant environmental factor inducing melanoma
(Gilchrest et al., 1999). In particular, exposure to UVB has
been identified by many biological (Berking et al., 2004; De
Fabo et al., 2004) and epidemiological studies (Fears et al.,
2002; Autier et al., 2003) as a major factor of melanoma
initiation and promotion.
UVB exposure has been shown to induce apoptosis
through at least three pathways (Kulms et al., 2002). The
most important one is associated with DNA damage, which
activates the mitochondrial pathway. UVB can also activate
the death receptor pathway by inducing the clustering of cell
death receptors such as CD-95 (Fas/Apo-1) in the absence of
ligand (Aragane et al., 1998). Finally, UVB exposure can
generate reactive oxygen species, which stimulate cyto-
chrome c release from mitochondria into the cytoplasm and
subsequently apoptosis (Kulms et al., 2002). In melanoma
cells, studies have shown that UVB irradiation can both
induce mitochondrial (Bivik et al., 2006) and Caspase-
independent apoptotic pathways (Liu et al., 2006), but also
stimulate proliferation (van Schanke et al., 2005).
In an attempt to clarify this issue, we investigated the
molecular mechanisms linking UVB and melanoma, through
analysis of UVB effects at doses comparable with those
received by melanocytes under physiological conditions at
the basal layer of epidermis: between 50 and 150 J/m2
corresponding to 2–6 MED (Minimum Erythemal Dose) at
skin surface (Pedeux et al., 2006). Thus, we had previously
shown that, unlike keratinocytes or fibroblasts, melanocytes,
and melanoma cells respond to UVB by activating an original
pathway involving the upregulation of GADD45A expression
even in the absence of active p53 (Lefort et al., 2001; Pedeux
et al., 2002). GADD45A is one of several growth-arrest and
DNA-damage-inducible genes (Fornace et al., 1988). As
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indicated by its name, Gadd45a is involved in DNA damage
response and can regulate various processes: G2 cell cycle
arrest, apoptosis, DNA repair, and genomic stability (for
review, Maeda et al., 2002). Nevertheless, its precise role in
these events appears to depend on stress and cell type. In
melanoma cells, we have shown that Gadd45a induction by
low UVB doses leads to a G2 cell cycle arrest associated with
Cdc2 sequestration in nuclear speckles (Fayolle et al., 2006).
The role of Gadd45a in apoptosis is controversial (for
review, Zhan, 2005). In many models, Gadd45a appears to
act as a proapoptotic protein (Takekawa and Saito, 1998;
Tong et al., 2001; Hildesheim et al., 2002). On the other
hand, several studies have associated Gadd45a with cell
survival (Smith et al., 1996; Maeda et al., 2002; Schneider
et al., 2006) and even resistance to apoptosis (Smith and
Mocarski, 2005; Gupta et al., 2006).
To further analyze the role of Gadd45a in apoptosis of
melanocytes, we investigated the effect of Gadd45a inactiva-
tion on melanoma cell survival following UVB irradiation.
RESULTS
Gadd45a inactivation prevents the proliferation of melanoma
cells
During the process of selection of melanoma cells with
knocked down Gadd45a expression, we observed a decrease
in cell survival. Indeed, the transfection of the M4Be
melanoma cell line with plasmids encoding different small
hairpin RNA (shRNA) targeting Gadd45a mRNA (pSR-sh45-2
and pSR-sh45-6), resulted in a dramatic decrease of the
number of colonies (58.1 and 90.2% respectively) as
compared with clones containing plasmid encoding non-
targeting shRNA (pSR-shSC). Giemsa staining of resulting
colonies illustrates this observation (Figure 1) that was
confirmed throughout several independent experiments.
Inactivation of GADD45A overexpression sensitizes melanoma
cells to UVB-induced cell death
Several independent clones of M4Be transfected with
plasmids encoding different shRNA targeting Gadd45a
mRNA (pSR-sh45-2 and pSR-sh45-6) or the control shRNA
(pSR-shSc) were isolated. For each plasmid, several clones
were derived and Gadd45a expression following or not UVB
exposure was analyzed by reverse transcription-PCR and
Western blot. Surprisingly, the basal level of Gadd45a was
not affected in clones obtained using pSR-sh45-2, and only
slightly using pSR-sh45-6 (Figure 2a). Following UVB
exposure, the induction of Gadd45a was lowered in both
clones containing Gadd45a-specific shRNA as compared
with clones transfected with the control shRNA or to parental
M4Be cells. Reverse transcription-PCR analyses indicated
that UVB induction of Gadd45a was divided by 2.5 in clones
containing the pSR-sh45-2 plasmid and by 10 in those
containing pSR-sh45-6 as compared with M4Be cells (Figure
S1). Comparison of cell cycle profiles following UVB
irradiation with 100 J/m2 showed that a wide proportion of
Gadd45a defective cells were present in the subG1 popula-
tion corresponding to dying cells (Figure 2b). Furthermore,
the proportion of cells in subG1 appeared to be higher in
clones containing pSR-sh45-6, also shown to display the
strongest inhibition of UVB-induced expression and of colony
formation. The same observations were made with several
selected clones (data not shown).
Gadd45a protects melanoma cells from UVB-induced apoptosis
We previously showed that Gadd45a-deficient melanoma
cells lack the G2 checkpoint following UVB exposure
(Fayolle et al., 2006). Then, we could suspect that these
cells undergo mitotic catastrophe rather than apoptosis. In
order to discriminate apoptosis from mitotic catastrophe, we
exposed melanoma cells expressing or not Gadd45a to either
100 J/m2 UVB irradiation or Paclitaxel, a drug known to
induce mitotic catastrophe. Hoechst staining of nuclei
24 hours after treatment showed that, contrary to Paclitaxel-
treated cells, no mitotic catastrophe could be observed in
UVB-treated cells. Instead, the majority of UVB-treated cells
contained condensed DNA, a characteristic of apoptotic
cells, and this proportion was much higher in Gadd45a-
defective cells (Figure S2).
We then analyzed the cleavage of Pro-caspase-3 and its
activity in M4Be cells and downregulated Gadd45a-derived
clones. Caspase-3 activation was first analyzed through a
time course of Pro-caspase-3 cleavage in active Caspase-3
(Figure 3a). In Gadd45a-defective clones Pro-caspase-3
amount was significantly reduced 8 hours after UVB exposure
with a minimum level after 24 hours. UVB exposure of M4Be
and control clone also induced Pro-caspase-3 cleavage but to
a lesser extent, as confirmed by a higher proportion of
cleaved Caspase-3 in Gadd45a-defective clones 24 hours
after UVB treatment. The increased activation of Caspase-3
was further determined by measuring Caspase-3 activity
24 hours after exposure of M4Be cells and clones to various
UVB radiation intensities (Figure 3b). As expected, Caspase-3
activity was systematically found increased in Gadd45a-
defective clones, with higher discrepancy for low UVB doses.
The activation was specific, as it was inhibited in the
presence of the Caspase-3-specific inhibitor N-acetyl-Asp-
Glu-Val-Asp-CHO (aldehyde) (DEVD-CHO) and of the
general Caspase inhibitor z-VAD-FMK (Z-Val-Ala-Asp-
(OCH3)-Fluoromethylketone) (Figure 3b). These results were
observed using several independent pSR-sh45-2- and pSR-
sh45-6-derived clones.
pSR-shSc pSR-sh45-2 pSR-sh45-6
Figure 1. Gadd45a inactivation prevents proliferation of melanoma cells.
M4Be melanoma cells were either mock transfected or transfected with the
pSuper-Retro vector (Brummelkamp et al., 2002) containing a small
hairpin sequence allowing downregulation of Gadd45a (pSR-sh45-2 and
pSR-sh45-6) or a non-targeting sequence (pSR-shSc). After 2 weeks of
puromycin selection, cells were stained with Giemsa.
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The mitochondrial pathway is involved in UVB-induced
apoptosis
To further determine the apoptotic pathway induced in
response to UVB exposure, a kinetic analysis of Bcl-xL
intracellular level after irradiation was performed. As shown
in Figure 4, the amount of Bcl-xL decreased 8 hours after UVB
exposure both in M4Be cells and derived clones but,
interestingly, became undetectable only in Gadd45a defi-
cient cells.
Gadd45a inactivation also enhances apoptosis induced by
chemotherapeutic agents
Finally, we analyzed whether the inactivation of Gadd45a
could sensitize melanoma cells to classical drugs. M4Be cells
and derived clones were treated with increasing doses of
Cisplatin or Dacarbazine (DTIC) and cell survival was
assessed by Giemsa staining. After 24 hours, cell density
was much higher in Gadd45a proficient than in Gadd45a-
defective melanoma cells (Figure 5a). Dose effects of both
drugs were evaluated by Trypan blue exclusion and
Gadd45a-deficient cells appeared to be much more sensitive
to both drugs (Figure 5b and c).
DISCUSSION
Melanocytes are known to be particularly resistant to
apoptosis. This ability to survive severe stress may be at
least in part responsible for the capacity of melanoma cells to
resist both chemotherapeutic agents and ionizing radiation
(Soengas and Lowe, 2003). Melanocytes are also resistant to
UV radiation (Gilchrest et al., 1999). We had previously
observed that UVB irradiation of melanoma cells induces
dose-dependent cell death (Pedeux et al., 2002; Fayolle et al.,
2006). Furthermore, UVB irradiation of human melanocytes
and melanoma cells specifically induces the overexpression
of Gadd45a (Pedeux et al., 2002). As GADD45A was
primarily considered as a proapoptotic gene, the observed
cell death could have been attributed to its induction
by UVB. Indeed, GADD45A has been reported as being
able to activate the mitochondrial pathway of apoptosis
(Takekawa and Saito, 1998). In this study, investigating the
role of Gadd45a in melanoma cell survival and apoptosis
following UVB exposure, we show that irradiation of
melanoma cells with 100 J/m2 led to a relatively low
proportion of dying cells (8%) despite a strong induction
of Gadd45a (Figure 2).
In order to further determine whether GADD45A induces
or prevents apoptosis of melanoma cells, we generated
several melanoma-derived clones with defective activa-
tion of Gadd45a using two different shRNA. During the
selection of these clones, we noticed that the inhibition
of Gadd45a expression reduced colony formation and that
this reduction was correlated with the ability of shRNA to
inhibit Gadd45a expression. Moreover, none of the clones
exhibited a complete inhibition of Gadd45a expression.
These observations were unexpected, as Gadd45a had
first been reported to prevent colony formation (Zhan et al.,
1994), but are in agreement with other studies indicating
that Gadd45a could also be necessary for cell survival
(Smith et al., 1996; Maeda et al., 2002; Schneider et al.,
2006). Furthermore, Gadd45a-defective clones exhibited
M4Be pSR-shSc pSR-sh45-2 pSR-sh45-6
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Figure 2. Gadd45a downregulation leads to increased UVB sensitivity. (a) Detection of Gadd45a by Western blot analysis of control and UVB (100 J/m2)-
treated M4Be cells and derived clones containing either a non-targeting shRNA (pSR-shSc) or Gadd45a-specific shRNAs (pSR-sh45-2 and pSR-sh45-6). Loading
of proteins was standardized by b-actin revelation. (b) Flow cytometry analysis of M4Be cells and derived clones following 100 J/m2 UVB irradiation.
Asynchronous cultures of M4Be cells were exposed to 100 J/m2 UVB and harvested 24 hours after irradiation. Experiments were performed three times with
similar results. A corresponds to the percentage of cells in subG1 and was calculated using CELLQUEST software (Becton Dickinson, France).
198 Journal of Investigative Dermatology (2008), Volume 128
C Fayolle et al.
Gadd45a Prevents Apoptosis of Melanoma Cells
dramatically increased sensitivity to UVB-induced cell
death, as compared with control clones or parental cells.
This observation associated with our previous results that
these cells escape G2 arrest (Fayolle et al., 2006) suggested
that they could undergo abnormal mitosis leading to
cell death, a phenomenon called mitotic catastrophe.
Comparison of nuclei morphologies of cells exposed to
UVB or treated with Paclitaxel, a drug known to induce
mitotic catastrophe (Blagosklonny et al., 2006), clearly
indicated that UVB-exposed Gadd45a-deficient melanoma
cells undergo apoptosis rather than mitotic catastrophe.
Caspase-3 cleavage and activity were involved in the
observed cell death, as confirmed by the suppression of
Caspase-3 activity by both a Caspase-3-specific inhibitor and
a Pan-Caspase inhibitor. Altogether, these results clearly
indicate that Gadd45a inhibition sensitizes melanoma cells
to UVB-induced apoptosis.
The involvement of Gadd45a in apoptosis inhibition
through its interaction with Bcl-xL has been recently
described (Smith and Mocarski, 2005). We observed that
following UVB exposure, Bcl-xL intracellular level decreased
in Gadd45a-defective cells. This indicates that Gadd45a may
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participate in the maintenance of Bcl-xL concentration
counterbalancing proapoptotic proteins of the Bcl2 family
(Smith and Mocarski, 2005). Therefore, it appears that
Gadd45a inhibits, at least partially, the mitochondrial
apoptotic pathway activated in UVB-exposed melanoma
cells.
As melanocytes share with melanoma cells, a high
resistance to apoptosis and an ability to specifically induce
Gadd45a in response to UVB exposure, we can hypothesize
that Gadd45a also has a protective role in the response of
melanocytes to low doses of UVB. Much like p53 in other
models, Gadd45a activation leads to cell cycle arrest and
facilitates DNA repair (Maeda et al., 2002). Nonetheless,
instead of inducing apoptosis, Gadd45a allows melanocytes
to overcome the induction of cell death by maintaining high
level of Bcl-xL, a major inhibitor of the mitochondrial
apoptotic pathway. Similarly, in melanoma development,
UVB-induced activation of Gadd45a may allow melanoma
cells to overcome apoptosis.
Finally, we show that the ability of Gadd45a to prevent
apoptosis can be extended to other types of stress, as its
inactivation also sensitizes melanoma cells to chemother-
apeutic agents used in the treatment of melanomas such as
DTIC and Cisplatin. These observations suggest that Gadd45a
inactivation could be a useful way to sensitize melanomas to
chemotherapy.
MATERIALS AND METHODS
Primary antibodies
Antibodies to Gadd45a (sc-797) and b-actin (sc-1616) were
commercially available from Santa Cruz Biotechnology (Tebu-bio,
France). Antibodies to Bcl-xL (2764) and Caspase-3 (9662) were
provided by Cell signaling technology (Ozyme, Montigny-le-
Bretonneux, France). Antibodies to Ku-80 were provided by Serotec
(Cergy-Saint-Christophe, France) .
Cell culture
The human melanoma cell line M4Be previously established in the
laboratory (Jacubovich et al., 1985) expresses a wild-type p53
protein (Dr JC Madelmont, personal communication). Cells were
cultured as described previously (Fayolle et al., 2006).
Cell treatments
For UVB exposure exponentially growing cells were irradiated with
a Spectrolinker XL 1000 (Spectronics Corporation, Westbury, NY) as
described previously (Fayolle et al., 2006). For drug treatments,
DTIC and Cisplatin were added to the culture medium during
24 hours. Cells were then washed with phosphate-buffered saline
and analyzed using Giemsa or Trypan Blue.
Colony formation analysis
M4Be melanoma cells were transfected with the pSuperRetro
plasmid containing either control shRNA (pSR-shSc) or Gadd45a-
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Figure 5. Gadd45a inactivation sensitizes melanoma cells to therapeutic agents. (a) M4Be cells and derived clones exposed to DTIC (400 mg/ml) or Cisplatin
(8 mg/ml) were stained with Giemsa 24 hours after treatment. (b and c) Cell survival was evaluated by Trypan blue exclusion 24 hours after exposure of
M4Be cells and derived clones to (b) DTIC or (c) Cisplatin. The percentage of surviving cells was obtained by enumerating Trypan blue-negative cells
versus the total number of cells.
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specific shRNAs (pSR-sh45-2 and pSR-sh45-6), using Lipofectamine
2000 (Invitrogen, Carlsbad, CA) as described previously (Fayolle
et al., 2006). Twenty-four hours after transfection, cells were
replated, and exposed to puromycin (0.6 mg/ml). Colony-forming
efficiency was determined 14 days after transfection. Cells were
rinsed twice with phosphate-buffered saline, fixed with methanol
100% and stained with Giemsa dye for 25 minutes.
Determination of sub-G1 population by flow cytometry
DNA content was measured by flow cytometry using propidium
iodide staining as described previously (Fayolle et al., 2006). Shortly,
24 hours after UVB treatment, melanoma cells were harvested and
resuspended in 1 ml trisodium citrate (4mM) containing 0.05% NP-40
(Igepal) and 50 mg/ml propidium iodide (Sigma, Saint Quentin
Fallavier, France). Staining was determined using a FACSCalibur
flow cytometer (Becton Dickinson, Pont de Claix, France). The
percentage of cells in sub-G1 was calculated using CELLQUEST
software (Becton Dickinson, France).
Western blot
Cells were lyzed in ice-cold-modified radioimmunoprecipitation
assay buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 2 mM EDTA, 1%
NP-40) supplemented with protease inhibitor cocktail (Complete
Mini, EDTA-free, Roche, Rosny sous Bois, France) at 41C. Protein
concentration in lysates was determined by the Bradford method
using commercially prepared reagents (Bio-Rad, Mames la coquette,
France). Proteins were separated by SDS-PAGE and transferred to a
polyvinylidene difluoride membrane (Bio-Rad). After saturation with
5% milk in phosphate-buffered saline membranes were incubated
with the primary antibody diluted in 1% dry milk in phosphate-
buffered saline-Tween 20 (0.5%), extensive washed in phosphate-
buffered saline-Tween 20 (0.5%), then incubated with the peroxide-
conjugated second antibody (Jackson Laboratories, West Grove, PA).
The binding of antibodies was detected using an enhanced
chemiluminescence detection system (ECL, Amersham, Saclay,
France). The membrane was reprobed with a monoclonal anti-b-
actin antibody or a polyclonal serum anti-Ku-80 protein used as
controls for protein loading and transfer.
Caspase-3 activity measurement
Caspase-3 activity was measured by the ApoAlert Caspase-3
Fluorescent Assay Kit from Clontech (Becton Dickinson, Palo Alto,
CA) according to the manufacturer’s instruction, using the
Ac-DEVD-AFC (N-acetyl-Asp-Glu-Val-Asp-7-amino-4-trifluoromethyl-
coumarin) substrate. Emitted fluorescence corresponding
to Caspase-3 activity was quantified using a cytofluorimeter
(PerSeptive Biosystem, Framingham, MA) with excitation at
485 nm and emission at 505 nm. Presented results correspond
to the ratio between detected fluorescence and the protein
concentration determined by the Bradford assay. Broad spectrum
Caspase inhibitor zVAD-FMK and Caspase-3 inhibitor DEVD-CHO
(Biomol, Plymouth Meeting, PA) were added following the
manufacturer’s instructions.
Analysis of cell survival
Viability was assessed by Trypan blue exclusion analysis. The
percentage of viability was obtained by enumerating Trypan blue-
negative cells versus the total number of cells.
For this study, experiments were realized in accordance with
INSERM and Centre Le´on Be´rard ethical policies.
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Figure S1. Inhibition of GADD45A induction following UVB by specific
shRNAs.
Figure S2. UVB-exposure results in apoptosis, whereas Paclitaxel provokes
mitotic catastrophe.
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